Valeant Pharmaceuticals International IncVRX:TOR

134.34
1.10 / 0.83%
350.56k
32.97 %
0.8887
Close in CADToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Feb 05 2016 21:00 GMT.

Summary

On Friday, Valeant Pharmaceuticals International Inc (VRX:TOR) closed at 134.34, 45.00% above the 52 week low of 92.65 set on Nov 18, 2015.

52-week range
Today
92.65
Nov 18 2015
347.84
Aug 06 2015
Markit short selling activity
Low
Medium
High
Open133.35
Day high135.90
Day low131.78
Bid134.32
Offer134.56
Previous close133.24
Average volume597.18k
Shares outstanding341.19m
Free float335.77m
P/E (TTM)54.84
Market cap45.46bn CAD
EPS (TTM)2.43 CAD
Data delayed at least 15 minutes, as of Feb 05 2016 21:00 GMT.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Valeant Pharmaceuticals International Inc+4.14 %-4.83 %-58.70 %-32.97 %+239.76 %
TSX-Toronto Stock Exchange 300 Compo-0.45 %-1.21 %-10.76 %-15.61 %-7.45 %
CA/HEALTH CARE+3.97 %-5.08 %-157.79 %-56.59 %+58.11 %
CA/PHARMACEUTICALS+3.97 %-5.08 %-157.79 %-49.20 %+70.57 %
Data delayed at least 15 minutes, as of Feb 05 2016 21:00 GMT.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.